Drug
Be1116
Be1116: highest development phase Phase 3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| BE1116 NCT07094087 | Phase 3 | Complex Cardiovascular Surgery With Cardiopulmonary Bypass |
Latest
No recent events.
Follow Be1116 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.